PRESS RELEASE Utrecht, the Netherlands, Oct. 6, 2022 – The research group of Dr. Patrick Kemmeren of the Princess Máxima Center for pediatric oncology will […]
Omnigen is looking for a PhD candidate for the project “Statistics for Biologists: Leveraging user design for transcriptomics analysis”. Statistics and mathematics underpin the algorithms […]
We are delighted to announce that our new project ‘ISOLATE’ (DIagnoStic tOol Liver cAncer TreatmEnt) with Levels Diagnostics has been granted the MIT R&D collaboration […]
We are very happy to announce that, together with ShanX Medtech BV, our project to develop a rapid diagnostic tool for Urinary Tract Infection (UTI) […]
Two vacancies for the position: Data scientist/software engineer / bioinformatician, with solid software engineering affinity and skills Do you want the chance to make […]
To market the PITA tool as a diagnostic platform for pancreatic cancer patients, a total of 1.38 million euros will be invested by Omnigen B.V., […]
The great Feyenoord DNA study, of which Omnigen was a part of, has won the European Sponsorship Awards For this study We figured out if […]
GetFundend is a program of the municipality of Rotterdam that helps innovative startups and scaleups with European grant applications. Seven companies got selected to get […]
You can now find Omnigen on the partners page of Google Cloud. We are officially a partner of Google and we can help you with […]
Last night (2-12-18), Berry Kriesels CEO of Omnigen, was a guest on the Dutch tv show VPRO Tegenlicht. In this episode of the show, they […]
The FD (Dutch financial newspaper) wrote an article about Omnigen. They wrote about what we do, how we got where we are now and where […]
Last Saturday (13-10-18) a few employees and friends of Omnigen took on the ultimate challenge by joining the Strong Viking Brother Edition in Amsterdam. For […]
